Article Information
History
- April 28, 2021.
Article Versions
- Version 1 (January 25, 2021 - 13:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Bing Wang1,2,
- Vladimir Svetlov3,
- Yuri I Wolf4,
- Eugene V Koonin4,
- Evgeny Nudler3,5 and
- Irina Artsimovitch1,2,*
- 1Department of Microbiology and The Ohio State University, Columbus, OH 43210, USA
- 2The Center for RNA Biology, The Ohio State University, Columbus, OH 43210, USA
- 3Department of Biochemistry and Molecular Pharmacology, New York University School of Medicine, New York, NY 10016, USA
- 4National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USA
- 5Howard Hughes Medical Institute, New York University School of Medicine, New York, NY 10016, USA
- ↵* Corresponding author; email: artsimovitch.1{at}osu.edu
Posted April 28, 2021.
Allosteric activation of SARS-CoV-2 RdRp by remdesivir triphosphate and other phosphorylated nucleotides
